In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...

Data supplied by Morningstar and accurate on Aug 16, 2024. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...

Biohacking is a broad term for nonspecific lifestyle self-improvement. It may involve making incremental changes to one’s body, diet, and lifestyle to improve one’s health and well-being. Also ...

The conference is also supported by sponsors from both local and multinational companies, including Biotek Abadi Sdn Bhd, Profes Lipid Sdn Bhd, Boston Micro Fabrication, Gaia Science-SOTAX ...

Biomaterials are those materials — be it natural or synthetic, alive or lifeless, and usually made of multiple components — that interact with biological systems. Biomaterials are often used ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all of the ...

CAMBRIDGE, Mass., March 11, 2025--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb ...